Stephanie Kilmer represents public and private companies and private equity funds on cross-border and domestic mergers, acquisitions, dispositions, joint ventures and corporate reorganizations. Her experience spans a range of industries including retail and consumer products, healthcare, manufacturing, telecommunications, and technology.
Advised Symrise AG on the disposition of its chicken-based food ingredients business to Kerry
Advised Symrise AG on its $900 million acquisition of American Dehydrated Foods / International Dehydrated Foods
Advised Pfizer on worldwide restructuring in connection with its joint venture with GlaxoSmithKline to create a global consumer healthcare company
Advised Alter Domus on its acquisition of Cortland Capital Markets Services
Advised Pfizer on its disposition of Hospira Boulder, the US-based Active Pharmaceuticals Ingredients Business to Corden Pharma International GmBh
Advised Fortress Investment Group in connection with the US $233 million sale via auction of its portfolio of Phoenix life insurance settlements
Advised TBG AG on its US$900 million acquisition of Telvent DTN from Schneider Electric
Advised Pfizer on its US$900 million disposition of Hospira's Infusion Systems business to ICU Medical Inc.
Advised Oxford Finance LLC, a specialty finance firm, in connection with its acquisition by an affiliate of Wafra Capital Partners Inc.
Advised a Special Committee of the Board of Directors of Full Circle Capital Corporation in Full Circle's US$190 million merger with Great Elm Capital Corp.
Clifford Chance
